These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12230456)

  • 21. [Early Diagnosis of a Fetal Skeletal Dysplasia Associated with Increased Nuchal Translucency with 2D and 3D Ultrasound].
    Clementschitsch G; Hasenöhrl G; Steiner H; Staudach A
    Ultraschall Med; 2003 Oct; 24(5):349-52. PubMed ID: 14562214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between two- and three-dimensional ultrasound measurements of nuchal translucency.
    Clementschitsch G; Hasenöhrl G; Schaffer H; Steiner H
    Ultrasound Obstet Gynecol; 2001 Nov; 18(5):475-80. PubMed ID: 11844167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased nuchal translucency thickness at 10-14 weeks of gestation as a predictor of severe twin-to-twin transfusion syndrome.
    Sebire NJ; D'Ercole C; Hughes K; Carvalho M; Nicolaides KH
    Ultrasound Obstet Gynecol; 1997 Aug; 10(2):86-9. PubMed ID: 9286014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
    Zoppi MA; Ibba RM; Floris M; Monni G
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infantile hypophosphatasia: autosomal recessive transmission to two related sibships.
    Moore CA; Ward JC; Rivas ML; Magill HL; Whyte MP
    Am J Med Genet; 1990 May; 36(1):15-22. PubMed ID: 2333903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuchal translucency as a screening test for chromosomal abnormalities in a routine first trimester ultrasound examination.
    Josefsson A; Molander E; Selbing A
    Acta Obstet Gynecol Scand; 1998 May; 77(5):497-9. PubMed ID: 9654169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuchal translucency thickness and outcome in chromosome translocation diagnosed in the first trimester.
    Sepulveda W; Be C; Youlton R; Carstens E; Reyes M
    Prenat Diagn; 2001 Sep; 21(9):726-8. PubMed ID: 11559907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific osseous spurs in a lethal form of hypophosphatasia correlated with 3D prenatal ultrasonographic images.
    Sinico M; Levaillant JM; Vergnaud A; Blondeau JR; Encha-Razavi F; Mornet E; Le Merrer M; Gerard-Blanluet M
    Prenat Diagn; 2007 Mar; 27(3):222-7. PubMed ID: 17238218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal diagnosis of hypophosphatasia.
    Kousseff BG; Mulivor RA
    Obstet Gynecol; 1981 Jun; 57(6 Suppl):9S-12S. PubMed ID: 7243133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early prenatal sonographic diagnosis of congenital hypophosphatasia.
    Tongsong T; Pongsatha S
    Ultrasound Obstet Gynecol; 2000 Mar; 15(3):252-5. PubMed ID: 10846783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased nuchal translucency as a marker for fetal chromosomal defects.
    Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P
    N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrauterine lethality of trisomy 21 fetuses with increased nuchal translucency thickness.
    Hyett JA; Sebire NJ; Snijders RJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 1996 Feb; 7(2):101-3. PubMed ID: 8776233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypophosphatasia: nonlethal disease despite skeletal presentation in utero (17 new cases and literature review).
    Wenkert D; McAlister WH; Coburn SP; Zerega JA; Ryan LM; Ericson KL; Hersh JH; Mumm S; Whyte MP
    J Bone Miner Res; 2011 Oct; 26(10):2389-98. PubMed ID: 21713987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers.
    Makrydimas G; Sotiriadis A; Huggon IC; Simpson J; Sharland G; Carvalho JS; Daubeney PE; Ioannidis JP
    Am J Obstet Gynecol; 2005 Jan; 192(1):89-95. PubMed ID: 15672008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac defects in chromosomally normal fetuses with increased nuchal translucency at 10-14 weeks of gestation.
    Galindo A; Comas C; Martínez JM; Gutiérrez-Larraya F; Carrera JM; Puerto B; Borrell A; Mortera C; de la Fuente P
    J Matern Fetal Neonatal Med; 2003 Mar; 13(3):163-70. PubMed ID: 12820838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased fetal nuchal translucency: possible involvement of early cardiac failure.
    Montenegro N; Matias A; Areias JC; Castedo S; Barros H
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):265-8. PubMed ID: 9383878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency.
    Hafner E; Schuchter K; Philipp K
    Ultrasound Obstet Gynecol; 1995 Nov; 6(5):330-3. PubMed ID: 8590203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First trimester nuchal translucency: effective routine screening for Down's syndrome.
    Thilaganathan B; Sairam S; Michailidis G; Wathen NC
    Br J Radiol; 1999 Oct; 72(862):946-8. PubMed ID: 10673944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypically dissimilar hypophosphatasia in two sibships.
    Macfarlane JD; Kroon HM; van der Harten JJ
    Am J Med Genet; 1992 Jan; 42(1):117-21. PubMed ID: 1308350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fetal cardiac defects and increased nuchal translucency thickness: a prospective study.
    McAuliffe FM; Hornberger LK; Winsor S; Chitayat D; Chong K; Johnson JA
    Am J Obstet Gynecol; 2004 Oct; 191(4):1486-90. PubMed ID: 15507988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.